Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for N4 Pharma in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 3.57.
Current Consensus is
The current consensus among 0 polled investment analysts is to n/a stock in N4 Pharma. This N/A consensus rating has held steady for over two years.